AGM Information • Nov 13, 2023
AGM Information
Open in ViewerOpens in native device viewer
An Extraordinary General Mee1ng of Spineway shareholders was held on first no1ce on Friday, November 10, 2023 at 9:30 a.m. at the company's registered office, 7 allée Moulin Berger in Ecully (69).
Taking into account the representa1on of defaul1ng shareholders by SELARL TULIER POLGE ALIREZAI, as ad hoc agent appointed by Order of the President of the Commercial Court of Lyon dated October 30, 2023, the number of shares held by the shareholders present and represented was 31,898,246 shares and 31,893,331 vo1ng rights. As a quorum was reached, the Mee1ng was able to be held and make decisions normally.
All resolu1ons submi[ed to the Extraordinary General Mee1ng were adopted, including the first resolu1on concerning the capital reduc1on, mo1vated by losses, in a nominal amount of €1,531,115.81 through a reduc1on in the par value of each share from €0.05 to €0.002.
As a result, the Company's share capital has been reduced from €1,594,912.30 to €63,796.49, divided into 31,898,245 shares with a par value of €0.002 each.
Informa1on rela1ng to the Extraordinary General Mee1ng of 10 November 2023 is available on the Company's website under "Investors/Regulated Informa1on": h[ps://spineway.com/investors/regulatedinforma1on/.
This press release has been prepared in both English and French. In case of discrepancies, the French version shall prevail.
Spineway designs, manufactures and markets innova7ve implants and surgical instruments for trea7ng severe disorders of the spinal column.
Spineway has an interna7onal network of over 50 independent distributors and 90% of its revenue comes from exports. Spineway, which is eligible for investment through FCPIs (French unit trusts specializing in innova7on), has received the OSEO Excellence award since 2011 and has won the DeloiMe Fast 50 award (2011). Rhône Alpes INPI Patent Innova7on award (2013) – INPI Talent award (2015). ISIN: FR001400BVK2 - ALSPW
Contacts:
Shareholder-services line Available Tuesday through Thursday +33 (0)806 706 060
Investor rela:ons Solène Kennis [email protected]
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.